Tri Locum Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-17,260
Closed -$129K 37
2020
Q4
$129K Buy
+17,260
New +$129K 0.05% 63